Free Cash Flow to The Firm (FCFF)
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
Item | Description | The company |
---|---|---|
FCFF | Free cash flow to the firm is the cash flow available to the AmerisourceBergen Corp. suppliers of capital after all operating expenses have been paid and necessary investments in working and fixed capital have been made. | AmerisourceBergen Corp. FCFF increased from 2020 to 2021 and from 2021 to 2022. |
Interest Paid, Net of Tax
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
2 2022 Calculation
Interest paid, tax = Interest paid × EITR
= 219,800 × 23.70% = 52,093
Enterprise Value to FCFF Ratio, Current
Selected Financial Data (US$ in thousands) | |
Enterprise value (EV) | 41,299,807) |
Free cash flow to the firm (FCFF) | 2,380,779) |
Valuation Ratio | |
EV/FCFF | 17.35 |
Benchmarks | |
EV/FCFF, Competitors1 | |
Abbott Laboratories | 36.56 |
Cigna Group | 8.60 |
CVS Health Corp. | 8.70 |
Elevance Health Inc. | 9.74 |
Humana Inc. | 5.89 |
Intuitive Surgical Inc. | 242.34 |
Medtronic PLC | 20.77 |
UnitedHealth Group Inc. | 17.62 |
EV/FCFF, Sector | |
Health Care Equipment & Services | 16.95 |
EV/FCFF, Industry | |
Health Care | 18.65 |
Based on: 10-K (reporting date: 2022-09-30).
1 Click competitor name to see calculations.
If the company EV/FCFF is lower then the EV/FCFF of benchmark then company is relatively undervalued.
Otherwise, if the company EV/FCFF is higher then the EV/FCFF of benchmark then company is relatively overvalued.
Enterprise Value to FCFF Ratio, Historical
Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
---|---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | |||||||
Enterprise value (EV)1 | 36,473,156) | 30,235,610) | 20,514,111) | 18,995,014) | 20,769,340) | 18,335,740) | |
Free cash flow to the firm (FCFF)2 | 2,380,779) | 2,361,584) | 1,970,476) | 2,182,910) | 1,205,463) | 1,087,485) | |
Valuation Ratio | |||||||
EV/FCFF3 | 15.32 | 12.80 | 10.41 | 8.70 | 17.23 | 16.86 | |
Benchmarks | |||||||
EV/FCFF, Competitors4 | |||||||
Abbott Laboratories | 23.24 | 23.47 | 36.94 | 33.05 | — | — | |
Cigna Group | 13.38 | 14.17 | 9.16 | 10.24 | — | — | |
CVS Health Corp. | 10.00 | 10.30 | 9.42 | 12.30 | — | — | |
Elevance Health Inc. | 13.32 | 12.74 | 6.04 | 12.73 | — | — | |
Humana Inc. | 14.88 | 42.03 | 7.92 | 8.46 | — | — | |
Intuitive Surgical Inc. | 85.45 | 56.01 | 76.70 | 54.58 | — | — | |
Medtronic PLC | 20.32 | 33.84 | 21.43 | 22.07 | — | — | |
UnitedHealth Group Inc. | 19.30 | 22.21 | 15.82 | 17.51 | — | — | |
EV/FCFF, Sector | |||||||
Health Care Equipment & Services | 17.28 | 19.60 | 14.85 | 16.66 | — | — | |
EV/FCFF, Industry | |||||||
Health Care | 17.73 | 17.16 | 17.81 | 18.15 | — | — |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
3 2022 Calculation
EV/FCFF = EV ÷ FCFF
= 36,473,156 ÷ 2,380,779 = 15.32
4 Click competitor name to see calculations.
Valuation ratio | Description | The company |
---|---|---|
EV/FCFF | Enterprise value to free cash flow to the firm is whole company valuation indicator. | AmerisourceBergen Corp. EV/FCFF ratio increased from 2020 to 2021 and from 2021 to 2022. |